Taconic Capital Advisors’s Envoy Medical COCH Stock Holding History

Taconic Capital Advisors’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-723,787	Closed	-$7.31M	–	293
2022 Q4	$7.31M	Buy	723,787 +53,787	+8%	+$535K	0.21%	94
2022 Q3	$6.59M	Buy	670,000 +140,000	+26%	+$1.37M	0.16%	131
2022 Q2	$5.19M	Hold	530,000	–	–	0.14%	171
2022 Q1	$5.18M	Hold	530,000	–	–	0.14%	153
2021 Q4	$5.17M	Hold	530,000	–	–	0.15%	130
2021 Q3	$5.14M	Hold	530,000	–	–	0.14%	108
2021 Q2	$5.14M	Buy	+530,000	New	+$5.15M	0.12%	108

Other funds holding COCH

AMC

Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Taconic Capital Advisors's COCH Position: Q1 2023 in Review

Taconic Capital Advisors sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 723,787 shares — an estimated $7.31M sold.

Taconic Capital Advisors first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $7.31M in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

Taconic Capital Advisors reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
Taconic Capital Advisors sold 723,787 Envoy Medical shares in Q1 2023, an estimated $7.31M.
Taconic Capital Advisors first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
Taconic Capital Advisors's Envoy Medical position peaked at $7.31M in Q4 2022.
24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Taconic Capital Advisors's 13F filing for Q1 2023, filed 15 May 2023.